Business · 18/10/2002Updated: 10/17/2026 · 1 min read
FDA Announces Approval of OMB for In Vivo Radiopharmaceutical Regulations
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to extend its regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →